SMAD2 and atrial fibrillation: According to a recent research report, the expression level of LIPCAR in atrial fibrillation was strongly linked to the phosphorylation of TGF-β1 and Smad2/3, indicating that it controls atrial fibrosis through the TGF-β/Smad pathway [39].